Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1993 Dec;69(6):639-42; discussion 642-3. doi: 10.1136/adc.69.6.639

Effect of oral acyclovir against primary and secondary viraemia in incubation period of varicella.

S Suga 1, T Yoshikawa 1, T Ozaki 1, Y Asano 1
PMCID: PMC1062977  PMID: 8285774

Abstract

The effect of oral acyclovir (approximately 40 mg/kg daily in four divided doses) against primary and secondary viraemia of varicella zoster virus (VZV) was examined in 27 children susceptible to VZV who were exposed to the virus in their families and their clinical features were compared with those of 19 non-treated subjects. The infection was confirmed by a fluorescent antibody to membrane antigen assay in 11 (85%) of 13 children who received acyclovir for the first seven days after exposure to VZV and in 11 (79%) of 14 who received acyclovir for the next seven days. The geometric mean antibody titre of the former group was significantly higher than that of the latter group. Varicella developed in 10 (91%) and was subclinical in one (9%) in the former group, whereas a very mild disease occurred in three (27%) and was subclinical in eight (73%) in the latter group. The severity of varicella was significantly greater in the former group than that in the latter group. On the other hand, all of the control group developed typical varicella and their clinical features were more severe than those of the acyclovir administered group. These data indicate that oral acyclovir more effectively inhibits replication of VZV in secondary viraemia than that of the primary viraemia.

Full text

PDF
639

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asano Y., Albrecht P., Behr D. E., Neff B. J., Vickers J. H., Rastogi S. C. Immunogenicity of wild and attenuated varicella-zoster virus strains in rhesus monkeys. J Med Virol. 1984;14(4):305–312. doi: 10.1002/jmv.1890140403. [DOI] [PubMed] [Google Scholar]
  2. Asano Y., Albrecht P., Vujcic L. K., Quinnan G. V., Jr, Kawakami K., Takahashi M. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays. Pediatrics. 1983 Sep;72(3):291–294. [PubMed] [Google Scholar]
  3. Asano Y., Itakura N., Hiroishi Y., Hirose S., Nagai T., Ozaki T., Yazaki T., Yamanishi K., Takahashi M. Viremia is present in incubation period in nonimmunocompromised children with varicella. J Pediatr. 1985 Jan;106(1):69–71. doi: 10.1016/s0022-3476(85)80468-6. [DOI] [PubMed] [Google Scholar]
  4. Asano Y., Itakura N., Hiroishi Y., Hirose S., Ozaki T., Kuno K., Nagai T., Yazaki T., Yamanishi K., Takahashi M. Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients. J Infect Dis. 1985 Nov;152(5):863–868. doi: 10.1093/infdis/152.5.863. [DOI] [PubMed] [Google Scholar]
  5. Asano Y., Takahashi M. Studies on neutralization of varicella-zoster virus and serological follow-up of cases of varicella and zoster. Biken J. 1978 Mar;21(1):15–23. [PubMed] [Google Scholar]
  6. Asano Y., Yoshikawa T., Suga S., Kobayashi I., Nakashima T., Yazaki T., Ozaki T., Yamada A., Imanishi J. Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics. 1993 Aug;92(2):219–222. [PubMed] [Google Scholar]
  7. Balfour H. H., Jr, Kelly J. M., Suarez C. S., Heussner R. C., Englund J. A., Crane D. D., McGuirt P. V., Clemmer A. F., Aeppli D. M. Acyclovir treatment of varicella in otherwise healthy children. J Pediatr. 1990 Apr;116(4):633–639. doi: 10.1016/s0022-3476(05)81618-x. [DOI] [PubMed] [Google Scholar]
  8. Dunkle L. M., Arvin A. M., Whitley R. J., Rotbart H. A., Feder H. M., Jr, Feldman S., Gershon A. A., Levy M. L., Hayden G. F., McGuirt P. V. A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med. 1991 Nov 28;325(22):1539–1544. doi: 10.1056/NEJM199111283252203. [DOI] [PubMed] [Google Scholar]
  9. Grose C. Variation on a theme by Fenner: the pathogenesis of chickenpox. Pediatrics. 1981 Nov;68(5):735–737. [PubMed] [Google Scholar]
  10. Källander C. F., Gronowitz J. S., Olding-Stenkvist E. Varicella zoster virus deoxythymidine kinase is present in serum before the onset of varicella. Scand J Infect Dis. 1989;21(3):255–257. doi: 10.3109/00365548909035694. [DOI] [PubMed] [Google Scholar]
  11. Myers M. G., Connelly B. L. Animal models of varicella. J Infect Dis. 1992 Aug;166 (Suppl 1):S48–S50. doi: 10.1093/infdis/166.supplement_1.s48. [DOI] [PubMed] [Google Scholar]
  12. Ozaki T., Ichikawa T., Matsui Y., Nagai T., Asano Y., Yamanishi K., Takahashi M. Viremic phase in nonimmunocompromised children with varicella. J Pediatr. 1984 Jan;104(1):85–87. doi: 10.1016/s0022-3476(84)80596-x. [DOI] [PubMed] [Google Scholar]
  13. ROSS A. H. Modification of chicken pox in family contacts by administration of gamma globulin. N Engl J Med. 1962 Aug 23;267:369–376. doi: 10.1056/NEJM196208232670801. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES